Critical role of MARCO in crystalline silica-induced pulmonary inflammation

Sheetal A Thakur1, Celine A Beamer, Christopher T Migliaccio

  • 1Department of Biomedical and Pharmaceutical Sciences, The University of Montana, Center for Environmental Health Sciences, Missoula, MT 59812, USA.

Insights

The macrophage receptor with collagenous structure (MARCO) is crucial for clearing crystalline silica particles in the lungs. Its absence leads to increased inflammation and lung injury, exacerbating silicosis development.

Area of Science:

  • Pulmonary immunology
  • Toxicology
  • Cell biology

Background:

  • Chronic exposure to crystalline silica causes silicosis, a fibrotic lung disease.
  • The macrophage receptor with collagenous structure (MARCO) binds silica particles in vitro.
  • MARCO's role in in vivo silica clearance and inflammation is unclear.

Purpose of the Study:

  • To investigate the role of MARCO in crystalline silica-induced pulmonary inflammation and pathology in vivo.
  • To compare pulmonary responses to crystalline silica in wild-type (WT) and MARCO(-/-) mice.

Main Methods:

  • Crystalline silica instillation in WT and MARCO(-/-) mice.
  • Assessment of pulmonary macrophage MARCO expression.
  • Measurement of particle uptake by alveolar macrophages.
  • Analysis of inflammatory cell counts and cytokine levels.
  • Histological examination and hydroxyproline content for fibrosis.

Main Results:

  • MARCO expression on pulmonary macrophages increased specifically after crystalline silica exposure.
  • MARCO(-/-) mice showed impaired silica clearance and enhanced acute inflammation.
  • MARCO(-/-) lungs exhibited increased chronic inflammation but minimal differences in fibrosis at 3 months.

Conclusions:

  • MARCO is essential for efficient crystalline silica clearance in the lungs.
  • Absence of MARCO exacerbates innate pulmonary immune responses and acute lung injury following silica exposure.
  • MARCO plays a significant role in regulating pulmonary responses to crystalline silica in vivo.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: